VLA-4 as a Central Target for Modulating Neuroinflammatory Disorders.

导出原文传递

翻译打印收藏纠错

作者： Arnon Dias,Jurberg ^[1] ; Beatriz,Chaves ^[2] ; Lia Gonçalves,Pinho ^[3] ; João Hermínio Martins,da Silva ^[4] ; Wilson,Savino ^[2] ; Vinicius,Cotta-de-Almeida ^[5]

作者单位： Laboratory on Thymus Research, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil. ^[1] National Institute of Science and Technology on Neuroimmunomodulation (INCT-NIM), Oswaldo Cruz Institute, Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, Brazil. ^[2] Rio de Janeiro Research Network on Neuroinflammation (RENEURIN), Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil. ^[3] School of Medicine, Estácio de Sá University, Rio de Janeiro, Brazil. ^[4] Computational Modeling Group, Oswaldo Cruz Foundation (Fiocruz), Eusébio, Brazil. ^[5]

关键词 Integrin Migration Multiple sclerosis Natalizumab T cells

主题词中枢神经系统(Central Nervous System);人类(Humans);免疫疗法(Immunotherapy);整合素α4β1(Integrin alpha4beta1);淋巴细胞活化(Lymphocyte Activation)

DOI 10.1159/000518721

PMID 34515173

发布时间 2021-12-14

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交